All treatments
Treatment
Matching Placebo (Remternetug) clinical trials
2 indexed studies · 2 currently recruiting
- RecruitingPHASE2, PHASE3
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
This study looks into new treatments for a rare, inherited form of Alzheimer's disease. Researchers want to see if these drugs can stop or slow down the disease in people who are at high risk or in the very early stages, based on their family history and genes.
For: Alzheimers Disease · Dementia · Alzheimers Disease, FamilialUnited States · Argentina · Australia - RecruitingPHASE2, PHASE3
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
This study is looking into a new treatment called remternetug for people who are at risk of developing a specific type of early-onset Alzheimer's disease due to their genes. It aims to see if the treatment can slow down or stop the disease before symptoms appear.
For: Alzheimers Disease · Dementia · Alzheimers Disease, FamilialUnited States · Argentina · Australia